Successful treatment of enterovirus-infected mice by 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine.
Open Access
- 1 June 1976
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 143 (6) , 1367-1381
- https://doi.org/10.1084/jem.143.6.1367
Abstract
The spontaneous expression of ecotropic murine leukemia virus (MuLV) in spleen cells of BALB/c, C57BL/6 (B6), and derivative mice was examined as a function of age. The patterns of spontaneous virus induction in vivo correlate with the patterns of virus induction in vitro, which result from the action of two loci, Inc-l and Inb-l (7). Whereas mice carrying Inc-l or Inb-l have similar phenotypes in vitro, they have significantly different phenotypes in vivo. Mice of the Inb-l+/+ genotype, e.g., B6, rarely expressed MuLV, and the titer of MuLV recovered from rare MuLV-positive mice of this genotype was usually low. Mice of the Inc-l+/+ genotype, e.g., BALB/c, expressed low amounts of MuLV early in life, however, from 6-12 mo of age approximately one-half of the Inc-l+/+ mice expressed virus, frequently of high titer. Equal numbers of N-tropic and B-tropic MuLV were recovered from Inb-l+ mice, but predominantly N-tropic MuLV was recovered from Inc-l+ mice. Strains that carry dominant (+) alleles at both Inc-l and Inb-l show higher titers of MuLV earlier in life than strains that carry only Inc-l or Inb-l. The presence of dominant alleles at both loci results in the appearance of predominantly N-tropic virus early in life. These results demonstrate that the principal determinants of spontaneous virus expression in these low leukemic strains of mice are the In loci or genes linked to them. A further inference that can be drawn from these studies is that the appearance of B-tropic virus is by no means a random process but rather results from predictable patterns of MuLV expression and alteration.This publication has 16 references indexed in Scilit:
- PROTECTIVE ACTION OF BENZIMIDAZOLE DERIVATIVES AGAINST VIRUS INFECTIONS IN TISSUE CULTURE AND IN VIVOThe Lancet, 1969
- Antiviral ChemotherapyAnnual Review of Pharmacology, 1966
- Studies on the mechanism of poliovirus-induced cell damageVirology, 1965
- ANTIVIRAL ACTIVITY OF SELECTED BENZIMIDAZOLES.1963
- Heterogeneity of Coxsackie B4 virus: Two kinds of particles which differ in antibody sensitivity, growth rate, and plaque sizeVirology, 1962
- Differences in the selective virus inhibitory action of 2-(α-hydroxybenzyl)-benzimidazole and guanidine · HClVirology, 1962
- Rapid Development of Drug-Resistant Mutants of PoliovirusScience, 1961
- 2-(α-Hydroxybenzyl)-benzimidazole (HBB) as an aid in virus classificationVirology, 1961
- SPECTRUM AND CHARACTERISTICS OF THE VIRUS INHIBITORY ACTION OF 2-(α-HYDROXYBENZYL)-BENZIMIDAZOLEThe Journal of Experimental Medicine, 1961
- EFFECTS OF CERTAIN PURINES AND RELATED COMPOUNDS ON VIRUS PROPAGATION1958